BEXMARILIMAB
UNII SA0O2AK3LA

Substance Identification & Data

This profile provides standardized clinical and technical data for Bexmarilimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) SA0O2AK3LA.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2259301-27-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
SA0O2AK3LA
CAS Registry Number
2259301-27-2
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
BEXMARILIMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
11328
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Bexmarilimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

BEXMARILIMAB

Common Names & Synonyms

ANTI-CLEVER-1 MONOCLONAL ANTIBODY FP-1305
BEXMARILIMAB [INN]
BEXMARILIMAB [WHO-DD]

Brand / Trade Names

CLEVEGEN

Systematic Nomenclature

IMMUNOGLOBULIN G4 (230-PROLINE,237-GLUTAMIC ACID) (ANTI-(HUMAN STABILIN 1)) (HUMANIZED MONOCLONAL FP-1305 .GAMMA.4-CHAIN), DISULFIDE WITH HUMANIZED MONOCLONAL FP-1305 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G4 (230-PROLINE,237-GLUTAMIC ACID), (ANTI-(HUMAN STABILIN 1)) (HUMAN-MUS MUSCULUS MONOCLONAL FP-1305 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL FP-1305 .KAPPA.-CHAIN, DIMER

Technical Codes

FP-1305